Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer

13 de diciembre de 2017 actualizado por: Jaime Miranda, Universidad Peruana Cayetano Heredia

This study aims to implement daily temperature measurements of feet complemented by SMS and voice messaging to prevent diabetic foot ulcers in patients with type 2 diabetes mellitus at high risk of ulceration.

Design: Physician-blinded, randomized, 18-month trial.

Setting: Diabetes outpatient clinics from two public hospitals

Population: Subjects will be eligible if they (1) have a diagnosis of type 2 diabetes mellitus, (2) are between 18 - 80 years of age, (3) have a present dorsalis pedis pulse in both feet, (4) are in risk group 2 or 3 using the diabetic foot risk classification system as specified by the International Working Group on the Diabetic Foot, (5) have an operating cell phone or a caregiver with an operating cell phone, and (6) have the ability to provide informed consent.

Hypothesis: The investigators hypothesize that implementation of an enhanced intervention that combines daily temperature measurement for the reduction of diabetic foot ulcer with SMS and voice messaging will improve patient measurement compliance and reduce diabetic foot ulcers in a middle income country.

Descripción general del estudio

Estado

Terminado

Condiciones

Descripción detallada

Detailed Description:

Thermometry is a promising emerging modality for the prevention of diabetic foot ulcers according to different clinical trials. However, patient compliance with self-monitoring temperature at home is a concern, as they may be forgetful or find it difficult to get into a consistent routine of daily monitoring. Therefore, the investigators propose to determine the utility of SMS and voice messaging to remind the patients to perform the thermometry, and to assess the impact on diabetic foot ulceration.

Specific Aims are:

  1. Compare the incidence of diabetic foot ulceration during the study between the arm that receives thermometry alone and the arm that receives thermometry plus SMS and voice messaging.
  2. Compare the compliance with foot thermometer use between the two study arms.
  3. Compare the frequency of alarms signs reported to the study nurse in the two study arms.
  4. Compare the frequency of alarms signs reported in the patient's logbooks in the two study arms.
  5. Compare the incidence of diabetic foot ulceration according to pre-specified sub-groups: caregiving status, and use of insoles and/or orthopedic shoes.
  6. In the intervention-only group, compare the incidence of diabetic foot ulcers by varying the recipient of the messaging intervention (patient vs caregivers).

Intervention:

  1. Placebo Comparator: Thermometry-only group. Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet through colors.

    Some alarm signs have been pre-specified: 1) When the thermal image shows yellow spots in any area of any feet for two consecutive days, 2) when the thermal image shows different colors in contralateral areas of the feet for two consecutive days or, 3) a dermal lesion is detected at any time. In any of these three scenarios, subjects will be instructed to contact the study nurse by phone or text message.

    For the first two types of alarm signs, once the study nurse is contacted he/ she will ask about the presence of lesions in the patient's feet and the patient's activity on the previous two weeks, and will provide recommendations on how to decrease activity until temperatures normalize. If TempStat measurements continue to show alarm signs for more than one week after the telephone consultation, the participant will be asked to contact the nurse and schedule a face-to-face evaluation to assess the presence of an infection and/or ulcer with a masked assessor.

    In the third type of alarm sign, presence of a dermal lesion, participants will be asked to contact the study's nurse and he/she will make an appointment for an evaluation with a nurse blind to the intervention.

    When the main outcome, foot ulceration, has been confirmed, patients will be directed by the study nurse to receive professional care by a specialist.

  2. Experimental: Thermometry plus SMS and voice messaging Thermometry-related intervention activities will be the same as those established for the thermometry-only group. In addition, this group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages has been developed and validated through both via SMS and voice messaging. During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both SMS and voice messaging. Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).

Tipo de estudio

Intervencionista

Inscripción (Actual)

172

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Lima, Perú, Lima 31
        • Hospital Cayetano Heredia
      • Lima, Perú, Lima 5
        • Hospital Nacional Arzobispo Loayza

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 80 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Diagnosis of type 2 diabetes mellitus.
  • Dorsalis pedis pulse in both feet.
  • In risk group 2 or 3 using the diabetic foot risk classification system as specified by the International Working Group on the Diabetic Foot.
  • Operating cell phone or a caregiver with an operating cell phone.
  • Ability to provide informed consent.

Exclusion Criteria:

  • Current ulcers or open amputation sites.
  • Active osteoarthropathy
  • Severe peripheral vascular disease
  • Foot infection

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador de placebos: Thermometry-only group

Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet.

Some alarm signs have been pre-specified: 1) thermal image shows yellow spots in any area of feet for two consecutive days, 2) thermal image shows different colors in contralateral areas of the feet for two consecutive days or, 3) a dermal lesion. In any of these three scenarios, subjects will be instructed to contact the study nurse by phone. (See Detailed Description for more detail on the actions after an alarm sign has been observed)

Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet. (See Detailed description)
Experimental: Thermometry plus SMS and voice messaging

Thermometry-related intervention activities will be the same as those established for the thermometry-only group. In addition, this group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages has been developed and validated through both SMS and voice messaging.

During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both via SMS and voice messaging.

Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).

Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet. (See Detailed description)

This group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages have been developed and validated their delivery through both, SMS and voice messaging.

During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both via SMS and voice messaging.

Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Foot ulceration
Periodo de tiempo: 18 months

The primary outcome is foot ulceration occurring at any point during the 12 month study duration.

Foot ulceration will be defined using the American Diabetes Association criteria, which defines ulcers as any break in the cutaneous barrier; that usually extend through the full thickness of the dermis. There will be two ways of identifying if a patient has developed foot ulceration: (1) during the clinical evaluations done by a nurse every 2 months. (2) In addition to these bimonthly assessments, patients will be advised to make telephone calls to the study's nurse to report the presence of an ulcer, and he/she will be asked to go to the hospital for a face-to-face evaluation to be conducted by a masked nurse.

18 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Adherence to daily temperature measurement
Periodo de tiempo: 18 months
Adherence to temperature measurements will be based on patient self-report of foot temperature monitoring through recording in patient's logbooks.
18 months
Report of an alarm sign to the nurse
Periodo de tiempo: 18 months
Compare the frequency of alarms signs reported to the study nurse
18 months
Report of an alarm sign in the logbook
Periodo de tiempo: 18 months
Compare the frequency of alarms signs reported in the patient's logbooks.
18 months
Dose-response analysis of SMS and voice messaging
Periodo de tiempo: 18 months
Dose-response per protocol analysis will be performed.
18 months
Glycosilated hemoglobin control targets
Periodo de tiempo: 18 months
Reduce of 1% or more of glycosylated hemoglobin.
18 months

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Sub-group analyses, all participants
Periodo de tiempo: 18 months

The primary outcome will be subjected to pre-specified heterogeneity in treatment effects. In the following analyses, variables will be considered positive if its presence/usage is reported at baseline and in at the last evaluation of the participant during study period.

  1. Caregiving status, assistance provided to the patient with i) basic activities of daily living, or ii) in the identification, prevention, or treatment of diabetes or any disability.
  2. Use of insoles and/or orthopedic shoes.
18 months
Sub-group analyses, intervention group only
Periodo de tiempo: 18 months
1)In order to receive the SMS and voice messaging, the intervention requires ownership of a cell phone by either the patient or its caregiver. This sub-group analysis will explore the primary outcome by the type of recipient (patient vs caregivers) of the messaging intervention.
18 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Jaime Miranda, MD, PhD, Universidad Peruana Cayetano Heredia

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de septiembre de 2015

Finalización primaria (Actual)

1 de septiembre de 2017

Finalización del estudio (Actual)

1 de octubre de 2017

Fechas de registro del estudio

Enviado por primera vez

20 de febrero de 2015

Primero enviado que cumplió con los criterios de control de calidad

26 de febrero de 2015

Publicado por primera vez (Estimar)

27 de febrero de 2015

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

15 de diciembre de 2017

Última actualización enviada que cumplió con los criterios de control de calidad

13 de diciembre de 2017

Última verificación

1 de agosto de 2017

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir